Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial

Hsu, 1996, Epidemiology of the eating disorders, Psychiatr Clin North Am, 19, 681, 10.1016/S0193-953X(05)70375-0

1994

Keel, 1997, Outcome in bulimia nervosa, Am J Psychiatry, 154, 313, 10.1176/ajp.154.3.313

Faris, 1992, Nociceptive, but not tactile, thresholds are elevated in bulimia nervosa, Biol Psychiatry, 32, 462, 10.1016/0006-3223(92)90134-L

Hadigan, 1992, Behavioral assessment of satiety in bulimia nervosa, Appetite, 18, 233, 10.1016/0195-6663(92)90200-P

Halmi, 1991, Temporal patterns of hunger and fullness ratings and related cognitions in anorexia and bulimia, Appetite, 16, 219, 10.1016/0195-6663(91)90060-6

Blundell, 1991, Pharmacological approaches to appetite suppression, Trends Pharmacol Sci, 12, 147, 10.1016/0165-6147(91)90532-W

Lautenbacher, 1991, Pain sensitivity in anorexia nervosa and bulimia nervosa, Biol Psychiatry, 29, 1073, 10.1016/0006-3223(91)90249-L

de Zwaan, 1996, Pain sensitivity, alexithymia, and depression in patients with eating disorders: are they related?, J Psychosom Res, 41, 65, 10.1016/0022-3999(96)00088-8

Randich, 1992, Vagal afferent modulation of nociception, Brain Res Rev, 17, 77, 10.1016/0165-0173(92)90009-B

Hartman, 1997, Ondansetron in bulimia nervosa (letter), Arch Gen Psychiatry, 54, 969, 10.1001/archpsyc.1997.01830220099014

Freeman, 1992, Selectivity of 5-HT3 receptor antagonists and anti-emetic mechanisms of action, Anticancer Drugs, 3, 79, 10.1097/00001813-199204000-00001

Galligan, 1996, Electrophysiological studies of 5-hydroxytryptamine receptors on enteric neurons, Behav Brain Res, 73, 199, 10.1016/0166-4328(96)00096-4

Champaneria, 1992, Identification and distribution of 5-HT3 recognition sites in the rat gastrointestinal tract, Br J Pharmacol, 106, 693, 10.1111/j.1476-5381.1992.tb14396.x

Blackshaw, 1993, Effects of 5-hydroxytryptamine on discharge of vagal mucosal afferent fibres from the upper gastrointestinal tract of the ferret, J Auton Nerv Syst, 45, 41, 10.1016/0165-1838(93)90360-7

Reynolds, 1991, Cisplatin-evoked induction of c-fos protein in the brainstem of the ferret: the effect of cervical vagotomy and the anti-emetic 5-HT3 receptor antagonist granisetron (BRL 43694), Brain Res, 565, 231, 10.1016/0006-8993(91)91654-J

Fukui, 1992, Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs, Jpn J Pharmacol, 59, 221, 10.1254/jjp.59.221

Ohuoha, 1994, The subnuclear distribution of 5-HT3 receptors in the human nucleus of the solitary tract and other structures of the caudal medulla, Brain Res, 637, 222, 10.1016/0006-8993(94)91236-X

Morales, 1996, Cellular and subcellular immunolocalization of the type 3 serotonin receptor in the rat central nervous system, Mol Brain Res, 36, 251, 10.1016/0169-328X(96)88406-3

Simpson, 1992, Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers, Psychopharmacology (Berl), 109, 497, 10.1007/BF02247730

First, 1994

Cooper, 1987, The eating disorder examination: a semi-structured interview for the assessment of specific psychopathology of eating disorders, Int J Eat Disord, 6, 1, 10.1002/1098-108X(198701)6:1<1::AID-EAT2260060102>3.0.CO;2-9

Hamilton, 1960, A rating scale for depression, J Neurol, Neurosurg, Psychiatry, 23, 56, 10.1136/jnnp.23.1.56

Beck, 1961, An inventory for measuring depression, Arch Gen Psychiatry, 4, 53, 10.1001/archpsyc.1961.01710120031004

Hamilton, 1959, A rating scale for anxiety, Br J Med Psychol, 32, 50, 10.1111/j.2044-8341.1959.tb00467.x

Beck, 1988, An inventory for measuring clinical anxiety: psychometric properties, J Consult Clin Psychol, 56, 893, 10.1037/0022-006X.56.6.893

Fawcett, 1987, Clinical management—imipramine/placebo administration manual. NIMH Treatment for Depression Collaborative Research Program, Psychopharmacol Bull, 23, 309

Faris, 1998, Effect of ondansetron, a 5-HT3 receptor antagonist, on the dynamic association between bulimic behaviors and pain thresholds, Pain, 77, 297, 10.1016/S0304-3959(98)00108-0